Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览10
暂无评分
关键词
bone metastases,solid tumors,double-blind,comparator-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要